Financial reports
10-K/A
2023 FY
Annual report (amended)
23 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K/A
2022 FY
Annual report (amended)
17 Apr 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
Current reports
8-K
Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice
21 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
15 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
22 Mar 23
8-K
Submission of Matters to a Vote of Security Holders
28 Nov 22
8-K
Other Events
2 Sep 22
8-K
Other Events
29 Jun 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5 Oct 21
8-K
Amendments to Articles of Incorporation or Bylaws
1 Oct 21
8-K
Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update
19 Aug 21
Registration and prospectus
S-8
Registration of securities for employees
8 Mar 22
S-3/A
Shelf registration (amended)
10 Sep 21
S-3
Shelf registration
13 Aug 21
424B5
Prospectus supplement for primary offering
2 Jul 21
S-3/A
Shelf registration (amended)
21 Jun 21
S-3
Shelf registration
4 Jun 21
424B4
Prospectus supplement with pricing info
28 Apr 21
424B4
Prospectus supplement with pricing info
28 Apr 21
S-1MEF
Registration of additional securities for an S-1
26 Apr 21
8-A12B
Registration of securities on exchange
26 Apr 21
Proxies
DEF 14A
Definitive proxy
2 Nov 23
DEF 14A
Definitive proxy
11 Oct 22
DEF 14A
Definitive proxy
8 Sep 21
DEF 14A
Definitive proxy
28 Aug 20
DEFA14A
Additional proxy soliciting materials
26 Aug 19
DEF 14A
Definitive proxy
12 Aug 19
DEF 14A
Definitive proxy
13 Jun 18
DEFA14A
Additional proxy soliciting materials
13 Jun 18
DEF 14A
Definitive proxy
26 May 17
DEFR14A
Revised proxy
4 May 16
Other
EFFECT
Notice of effectiveness
20 Sep 21
CORRESP
Correspondence with SEC
14 Sep 21
UPLOAD
Letter from SEC
18 Aug 21
EFFECT
Notice of effectiveness
24 Jun 21
CORRESP
Correspondence with SEC
21 Jun 21
UPLOAD
Letter from SEC
11 Jun 21
EFFECT
Notice of effectiveness
27 Apr 21
CERT
Certification of approval for exchange listing
26 Apr 21
CORRESP
Correspondence with SEC
23 Apr 21
CORRESP
Correspondence with SEC
23 Apr 21
Ownership
4
TIMOTHY R WRIGHT
1 Apr 24
4
Robert Benjamin Stein
29 Mar 24
4
Khalil Barrage
29 Mar 24
4
Jennifer Buell
29 Mar 24
4
GARO H ARMEN
29 Mar 24
4
Brian Corvese
29 Mar 24
4
Alexander K. Arrow
29 Mar 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Alexander K. Arrow
13 Oct 23
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 23